Product Information
ALBUTEROL SULFATE 4 MG TAB is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.4044 per EA under NDC 64980044301. Its NADAC has been published 417 times since Oct 10, 2018.
FDA first approved this application on Jun 29, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980044301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ALBUTEROL SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA207046FDA Approved
6/29/2018
TE Code
AB
On Market Since
6/29/2018
Pharmacological Classes
Price Statistics
The NADAC for ALBUTEROL SULFATE 4 MG TAB has been published 417 times since Oct 10, 2018, and over the history we have for it it has declined 89.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4044 per EA |
|---|---|
| All-time high | $3.9530 (Oct 10, 2018) |
| All-time low | $0.2300 (Apr 22, 2026) |
| 52-week high | $0.4524 |
| 52-week low | $0.2300 |
| Median price | $0.5750 |
| Average price | $1.0851 |
| Largest weekly change | +81.3% (Jun 21, 2023) |
| Weeks tracked | 417 |
| Tracking since | Oct 10, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the albuterol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
albuterol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta2-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALBUTEROL SULFATE 4 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ALBUTEROL SULFATE 4 MG TAB, manufactured by Rising Pharma Holdings Inc., is $0.4044 per EA (NDC 64980044301), effective Sep 30, 2026.
How has the price of ALBUTEROL SULFATE 4 MG TAB changed over time?
Over the history we have for it, the NADAC for ALBUTEROL SULFATE 4 MG TAB has declined 89.8%. It has been tracked across 417 weekly CMS publications since Oct 10, 2018.
What are the highest and lowest recorded NADAC prices for ALBUTEROL SULFATE 4 MG TAB?
Since Oct 10, 2018, the NADAC for ALBUTEROL SULFATE 4 MG TAB has ranged from a low of $0.2300 (Apr 22, 2026) to a high of $3.9530 (Oct 10, 2018), with a median of $0.5750 per EA.
Are there cheaper alternatives to ALBUTEROL SULFATE 4 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of ALBUTEROL SULFATE 4 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ALBUTEROL SULFATE 4 MG TAB?
ALBUTEROL SULFATE 4 MG TAB (NDC 64980044301) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.